Study of Intravenous Immunoglobulin in Amnestic Mild Cognitive Impairment

NCT01300728 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: NewGam 10% IVIG
OTHER: Placebo

Sponsor

Sutter Health